6XQU | Viral Protein Hydrolase | date | Jul 10, 2020 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Room-Temperature X-Ray Crystal Structure Of Sars-Cov-2 Main In Complex With Boceprevir | ||||||||||||||
authors | D.W.Kneller, A.Kovalevsky, L.Coates | ||||||||||||||
compound | source | ||||||||||||||
Molecule: 3c-Like Proteinase Chain: A Ec: 3.4.22.69 Engineered: Yes |
Organism_scientific: Severe Acute Respiratory Syndrome Coro 2; Organism_common: 2019-Ncov Organism_taxid: 2697049 Gene: Rep, 1a-1b Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
symmetry | Space Group: I 1 2 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.20 Å | ||||||||||||
ligand | U5G | enzyme | Hydrolase E.C.3.4.22.69 BRENDA | ||||||||||||
Primary reference | Malleability of the SARS-CoV-2 3CL M(pro) Active-Site Cavity Facilitates Binding of Clinical Antivirals., Kneller DW, Galanie S, Phillips G, O'Neill HM, Coates L, Kovalevsky A, Structure. 2020 Oct 23. pii: S0969-2126(20)30379-8. doi:, 10.1016/j.str.2020.10.007. PMID:33152262 |
Data retrieval |
View 6XQU in 3D |
Visual 3D analysis of 6XQU |
Structure-derived information |
Sequence-derived information |
Other resources with information on 6XQU |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |